Has Mayank Gupta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $783,653 in general payments to Mayank Gupta, MD across 866 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mayank Gupta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mayank Gupta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mayank Gupta, MD

Pain Medicine · Overland Park, KSNPI 1023104445

Payments from drug & device makers

$783,653in general payments, 2019–2025

Across 866 payments — averaging $904.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Scilex Pharmaceuticals Inc.$168K
Nevro Corp.$161K
GRT US Holding, Inc.$130K
Nalu Medical, Inc.$122K
Averitas Pharma Inc.$94K
Vertos Medical, Inc.$28K
plus $80K from 43 others

$67,650in research payments, 2019–2025

Across 242 payments — averaging $279.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Nevro Corp.$45K
Biotronik Inc.$22K

What the payments were for

Consulting fees$78,38339%
Speaking & faculty fees$73,45037%
Travel & lodging$19,77210%
Food & beverage$27,35314%
Entertainment$240%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Scilex Pharmaceuticals Inc.	9	$168,369
Nevro Corp.	98	$161,337
GRT US Holding, Inc.	122	$129,840
Nalu Medical, Inc.	69	$121,504
Averitas Pharma Inc.	61	$94,052
Vertos Medical, Inc.	38	$28,486
Boston Scientific	100	$18,226
SPR Therapeutics, Inc	17	$17,554
MDD US Operations, LLC	16	$8,394
Biotronik Inc.	6	$7,242
Spinal Simplicity, LLC	37	$6,017
Abbott	97	$3,971
Seikagaku Corporation	3	$2,890
Stryker	4	$2,527
Saluda Medical Americas, Inc.	32	$2,028
Foundation Fusion Solutions, LLC	13	$1,708
Globus Medical	2	$1,516
Surgentec	2	$1,490
Medtronic(2 entities)	20	$1,214
MML US, Inc.	11	$990
Vertiflex, Inc.	5	$725
Curonix LLC	8	$563
AbbVie(2 entities)	31	$518
Electronic Waveform Lab, Inc.	4	$317
Stimwave Technologies Incorporated	2	$297
Tersera Therapeutics LLC	12	$270
Painteq LLC	4	$256
Baudax Bio Inc.	5	$196
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$187
Tonix Medicines, Inc.	1	$124
Biotronik NRO, Inc.	2	$96
Biodelivery Sciences International, Inc.	1	$76
Amgen	4	$75
Pfizer	3	$72
Relievant Medsystems, Inc.	1	$72
Redhill Biopharma Inc.	1	$71
Fidia Pharma USA Inc.	4	$59
Vertex	2	$57
Pacira Therapeutics, Inc.	2	$49
Protega Pharmaceutials Inc	2	$39
Forte Bio-pharma LLC	2	$32
Bioventus LLC	1	$30
Titan Surgical Group, LLC	1	$21
Si-bone, Inc.	1	$20
Zyla Life Sciences, Inc.	1	$19
Collegium Pharmaceutical, Inc.	1	$16
Radius Health, Inc.	1	$14
Sentynl Therapeutics, Inc.	1	$13
Kaleo, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Qutenza$101,091
Senza Spinal Cord Stimulation System$32,321
Nalu Neurostimulation System$19,089
Lucemyra/Lofexidine$7,991
Omnia$4,693
ION Facet Screw$1,466
WaveWriter Alpha Prime 16$1,460
HA MINUTEMAN G3-R$1,288
mild Device Kit$1,058
Evoke$978
PROCLAIM$857
ReActiv8$835
Proclaim IPG$392
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$371
Superion Indirect Decompression System$307
Senza$274
GENERAL PAIN MANAGEMENT$255
PAINTEQ$192
ETERNA$177
Superion ISS$150

How this compares

$783,653 in reported general payments places this provider in the 95th percentile of 64 pain medicine providers in Kansas.

See all pain medicine providers in Kansas →

Medicare billing

Part B allowed, 2024

$129,702

Medicare patients

162

Services billed

4,999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	15	$223
Cephalexin	35	$196

Paid to pharmacies, not to this prescriber.

Other pain medicine in Overland Park

Jeffrey FosterOverland Park$86K
Brian KimOverland Park$61K
Jacob KneemanOverland Park$25K
Daniel NeumanOverland Park$18K
Allison BellOverland Park$13K
Mahoua RayOverland Park$11K
James SiglerOverland Park$10K
Raza JafriOverland Park$6K
Twinkal DalalOverland Park$6K
Zhengyu HuOverland Park$4K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →